Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

FAM35A associates with REV7 and modulates DNA damage responses of normal and BRCA1-defective cells.

Tomida J, Takata KI, Bhetawal S, Person MD, Chao HP, Tang DG, Wood RD.

EMBO J. 2018 May 22. pii: e99543. doi: 10.15252/embj.201899543. [Epub ahead of print]

PMID:
29789392
2.

Prospective Evaluation of Implantable Cardioverter-Defibrillator Lead Function During and After Left Ventricular Assist Device Implantation.

Hu YL, Kasirajan V, Tang DG, Shah KB, Koneru JN, Grizzard JD, Ellenbogen KA, Kron J.

JACC Clin Electrophysiol. 2016 Jun;2(3):343-354. doi: 10.1016/j.jacep.2016.01.008. Epub 2016 Mar 23.

PMID:
29766894
3.

Cancer stem cells: Regulation programs, immunological properties and immunotherapy.

Zhang D, Tang DG, Rycaj K.

Semin Cancer Biol. 2018 May 9. pii: S1044-579X(17)30280-8. doi: 10.1016/j.semcancer.2018.05.001. [Epub ahead of print] Review.

PMID:
29752993
4.

Internal Versus External Compression of a Left Ventricular Assist Device Outflow Graft: Diagnosis With Intravascular Ultrasound and Treatment With Stenting.

Trankle CR, Quader MA, Grizzard JD, Tang DG, Shah KB, Paris K, Shepard CK, Gertz ZM.

Circ Heart Fail. 2018 May;11(5):e004959. doi: 10.1161/CIRCHEARTFAILURE.118.004959. No abstract available.

PMID:
29695382
5.

Exercise Capacity in Patients with the Total Artificial Heart.

Canada JM, Evans RK, Abbate A, Arena R, Tang DG, Kasirajan V, Shah KB.

ASAIO J. 2018 Jan 10. doi: 10.1097/MAT.0000000000000746. [Epub ahead of print]

PMID:
29324512
6.

Histone 2B-GFP Label-Retaining Prostate Luminal Cells Possess Progenitor Cell Properties and Are Intrinsically Resistant to Castration.

Zhang D, Jeter C, Gong S, Tracz A, Lu Y, Shen J, Tang DG.

Stem Cell Reports. 2018 Jan 9;10(1):228-242. doi: 10.1016/j.stemcr.2017.11.016. Epub 2017 Dec 21.

7.

Molecular determinants of prostate cancer metastasis.

Rycaj K, Tang DG.

Oncotarget. 2017 Sep 19;8(50):88211-88231. doi: 10.18632/oncotarget.21085. eCollection 2017 Oct 20. Review.

8.

Transgenic overexpression of NanogP8 in the mouse prostate is insufficient to initiate tumorigenesis but weakly promotes tumor development in the Hi-Myc mouse model.

Liu B, Gong S, Li Q, Chen X, Moore J, Suraneni MV, Badeaux MD, Jeter CR, Shen J, Mehmood R, Fan Q, Tang DG.

Oncotarget. 2017 Apr 18;8(32):52746-52760. doi: 10.18632/oncotarget.17186. eCollection 2017 Aug 8.

9.

Numb-/low Enriches a Castration-Resistant Prostate Cancer Cell Subpopulation Associated with Enhanced Notch and Hedgehog Signaling.

Guo Y, Zhang K, Cheng C, Ji Z, Wang X, Wang M, Chu M, Tang DG, Zhu HH, Gao WQ.

Clin Cancer Res. 2017 Nov 1;23(21):6744-6756. doi: 10.1158/1078-0432.CCR-17-0913. Epub 2017 Jul 27.

PMID:
28751447
10.

Surgical Treatment of Heart Failure.

Higgins RSD, Kilic A, Tang DG.

Surg Clin North Am. 2017 Aug;97(4):923-946. doi: 10.1016/j.suc.2017.04.003. Review.

PMID:
28728723
11.

Cellular determinants and microenvironmental regulation of prostate cancer metastasis.

Rycaj K, Li H, Zhou J, Chen X, Tang DG.

Semin Cancer Biol. 2017 Jun;44:83-97. doi: 10.1016/j.semcancer.2017.03.009. Epub 2017 Apr 11. Review.

PMID:
28408152
12.

Infections in Patients with a Total Artificial Heart Are Common but Rarely Fatal.

Hidalgo LF, Shah KB, Cooke RH, Tang DG, Kasirajan V, Cooper HA, Aronow WS.

ASAIO J. 2017 Nov/Dec;63(6):736-739. doi: 10.1097/MAT.0000000000000562.

PMID:
28319520
13.

Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors that Can Function as a Cell of Origin for Prostate Cancer.

Zhang D, Lin K, Lu Y, Rycaj K, Zhong Y, Chao HP, Calhoun-Davis T, Shen J, Tang DG.

Stem Cells Transl Med. 2017 Mar;6(3):748-760. doi: 10.5966/sctm.2016-0243. Epub 2016 Sep 29.

14.

Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens.

Liu X, Krawczyk E, Suprynowicz FA, Palechor-Ceron N, Yuan H, Dakic A, Simic V, Zheng YL, Sripadhan P, Chen C, Lu J, Hou TW, Choudhury S, Kallakury B, Tang DG, Darling T, Thangapazham R, Timofeeva O, Dritschilo A, Randell SH, Albanese C, Agarwal S, Schlegel R.

Nat Protoc. 2017 Feb;12(2):439-451. doi: 10.1038/nprot.2016.174. Epub 2017 Jan 26.

PMID:
28125105
15.

MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes.

Liu C, Liu R, Zhang D, Deng Q, Liu B, Chao HP, Rycaj K, Takata Y, Lin K, Lu Y, Zhong Y, Krolewski J, Shen J, Tang DG.

Nat Commun. 2017 Jan 23;8:14270. doi: 10.1038/ncomms14270.

16.

NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis.

Jeter CR, Liu B, Lu Y, Chao HP, Zhang D, Liu X, Chen X, Li Q, Rycaj K, Calhoun-Davis T, Yan L, Hu Q, Wang J, Shen J, Liu S, Tang DG.

Cell Discov. 2016 Nov 15;2:16041. eCollection 2016.

17.

Impact of INTERMACS Profile on Clinical Outcomes for Patients Supported With the Total Artificial Heart.

Shah KB, Thanavaro KL, Tang DG, Quader MA, Mankad AK, Tchoukina I, Thacker LR, Smallfield MC, Katlaps G, Hess ML, Cooke RH, Kasirajan V.

J Card Fail. 2016 Nov;22(11):913-920. doi: 10.1016/j.cardfail.2016.04.016. Epub 2016 Apr 27.

PMID:
27131435
18.

miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.

Liu R, Liu C, Zhang D, Liu B, Chen X, Rycaj K, Jeter C, Calhoun-Davis T, Li Y, Yang T, Wang J, Tang DG.

Oncotarget. 2016 Aug 30;7(35):56628-56642. doi: 10.18632/oncotarget.10652.

19.

Generation of a C57BL/6 MYC-Driven Mouse Model and Cell Line of Prostate Cancer.

Ellis L, Ku S, Li Q, Azabdaftari G, Seliski J, Olson B, Netherby CS, Tang DG, Abrams SI, Goodrich DW, Pili R.

Prostate. 2016 Sep;76(13):1192-202. doi: 10.1002/pros.23206. Epub 2016 May 26.

PMID:
27225803
20.

ATXN7L3 and ENY2 Coordinate Activity of Multiple H2B Deubiquitinases Important for Cellular Proliferation and Tumor Growth.

Atanassov BS, Mohan RD, Lan X, Kuang X, Lu Y, Lin K, McIvor E, Li W, Zhang Y, Florens L, Byrum SD, Mackintosh SG, Calhoun-Davis T, Koutelou E, Wang L, Tang DG, Tackett AJ, Washburn MP, Workman JL, Dent SY.

Mol Cell. 2016 May 19;62(4):558-71. doi: 10.1016/j.molcel.2016.03.030. Epub 2016 Apr 28.

21.

Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer.

Chen X, Li Q, Liu X, Liu C, Liu R, Rycaj K, Zhang D, Liu B, Jeter C, Calhoun-Davis T, Lin K, Lu Y, Chao HP, Shen J, Tang DG.

Clin Cancer Res. 2016 Sep 1;22(17):4505-16. doi: 10.1158/1078-0432.CCR-15-2956. Epub 2016 Apr 8.

22.

Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer.

Zhang D, Park D, Zhong Y, Lu Y, Rycaj K, Gong S, Chen X, Liu X, Chao HP, Whitney P, Calhoun-Davis T, Takata Y, Shen J, Iyer VR, Tang DG.

Nat Commun. 2016 Feb 29;7:10798. doi: 10.1038/ncomms10798.

23.

Longitudinal tracking of subpopulation dynamics and molecular changes during LNCaP cell castration and identification of inhibitors that could target the PSA-/lo castration-resistant cells.

Rycaj K, Cho EJ, Liu X, Chao HP, Liu B, Li Q, Devkota AK, Zhang D, Chen X, Moore J, Dalby KN, Tang DG.

Oncotarget. 2016 Mar 22;7(12):14220-40. doi: 10.18632/oncotarget.7303.

24.

Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties.

Paranjape AN, Soundararajan R, Werden SJ, Joseph R, Taube JH, Liu H, Rodriguez-Canales J, Sphyris N, Wistuba I, Miura N, Dhillon J, Mahajan N, Mahajan K, Chang JT, Ittmann M, Maity SN, Logothetis C, Tang DG, Mani SA.

Oncogene. 2016 Nov 17;35(46):5963-5976. doi: 10.1038/onc.2015.498. Epub 2016 Jan 25.

25.

The total artificial heart.

Cook JA, Shah KB, Quader MA, Cooke RH, Kasirajan V, Rao KK, Smallfield MC, Tchoukina I, Tang DG.

J Thorac Dis. 2015 Dec;7(12):2172-80. doi: 10.3978/j.issn.2072-1439.2015.10.70. Review. Erratum in: J Thorac Dis. 2017 Mar;9(3):E342.

26.

Intraoperative Use of Vascular Ultrasound to Localize Thrombus in Left Ventricular Assist Device Exchange.

Smith ES, Nelson MT, Tang DG.

Anesth Analg. 2016 Jan;122(1):27-30. doi: 10.1213/ANE.0000000000000980. No abstract available.

PMID:
26678465
27.

Cancers of the breast and prostate: a stem cell perspective.

Tang DG.

Endocr Relat Cancer. 2015 Dec;22(6):E9-E11. doi: 10.1530/ERC-15-0427. No abstract available.

28.

Pulmonary Hypertension After Heart Transplantation in Patients Bridged with the Total Artificial Heart.

Shah R, Patel DB, Mankad AK, Rennyson SL, Tang DG, Quader MA, Smallfield MC, Kasirajan V, Shah KB.

ASAIO J. 2016 Jan-Feb;62(1):69-73. doi: 10.1097/MAT.0000000000000298.

PMID:
26479463
29.

Cell-of-Origin of Cancer versus Cancer Stem Cells: Assays and Interpretations.

Rycaj K, Tang DG.

Cancer Res. 2015 Oct 1;75(19):4003-11. doi: 10.1158/0008-5472.CAN-15-0798. Epub 2015 Aug 19. Review.

30.

Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications.

Deng Q, Tang DG.

Endocr Relat Cancer. 2015 Dec;22(6):T209-20. doi: 10.1530/ERC-15-0217. Epub 2015 Aug 18. Review.

31.

Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells.

Liu X, Chen X, Rycaj K, Chao HP, Deng Q, Jeter C, Liu C, Honorio S, Li H, Davis T, Suraneni M, Laffin B, Qin J, Li Q, Yang T, Whitney P, Shen J, Huang J, Tang DG.

Oncotarget. 2015 Sep 15;6(27):23959-86.

32.

Cancer stem cells and cell size: A causal link?

Li Q, Rycaj K, Chen X, Tang DG.

Semin Cancer Biol. 2015 Dec;35:191-9. doi: 10.1016/j.semcancer.2015.07.002. Epub 2015 Aug 1. Review.

33.

Regulation of NANOG in cancer cells.

Gong S, Li Q, Jeter CR, Fan Q, Tang DG, Liu B.

Mol Carcinog. 2015 Sep;54(9):679-87. doi: 10.1002/mc.22340. Epub 2015 May 27. Review.

34.

Maintenance Therapy Containing Metformin and/or Zyflamend for Advanced Prostate Cancer: A Case Series.

Bilen MA, Lin SH, Tang DG, Parikh K, Lee MH, Yeung SC, Tu SM.

Case Rep Oncol Med. 2015;2015:471861. doi: 10.1155/2015/471861. Epub 2015 Mar 15.

35.

Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions.

Jeter CR, Yang T, Wang J, Chao HP, Tang DG.

Stem Cells. 2015 Aug;33(8):2381-90. doi: 10.1002/stem.2007. Epub 2015 May 13. Review.

36.

Surveillance Endomyocardial Biopsy in the Modern Era Produces Low Diagnostic Yield for Cardiac Allograft Rejection.

Shah KB, Flattery MP, Smallfield MC, Merinar G, Tang DG, Sheldon EH, Thacker LR, Kasirajan V, Cooke RH, Hess ML.

Transplantation. 2015 Aug;99(8):e75-80. doi: 10.1097/TP.0000000000000615.

37.

MicroRNA-212 inhibits osteosarcoma cells proliferation and invasion by down-regulation of Sox4.

Luo XJ, Tang DG, Gao TL, Zhang YL, Wang M, Quan ZX, Chen J.

Cell Physiol Biochem. 2014;34(6):2180-8. doi: 10.1159/000369661. Epub 2014 Dec 2.

38.

Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells.

Rycaj K, Plummer JB, Yin B, Li M, Garza J, Radvanyi L, Ramondetta LM, Lin K, Johanning GL, Tang DG, Wang-Johanning F.

Clin Cancer Res. 2015 Jan 15;21(2):471-83. doi: 10.1158/1078-0432.CCR-14-0388. Epub 2014 Nov 4.

39.

Mechanical circulatory support devices in the ICU.

Shah KB, Smallfield MC, Tang DG, Malhotra R, Cooke RH, Kasirajan V.

Chest. 2014 Sep;146(3):848-857. doi: 10.1378/chest.13-2645. Review.

PMID:
25180728
40.

Implantation of the syncardia total artificial heart.

Tang DG, Shah KB, Hess ML, Kasirajan V.

J Vis Exp. 2014 Jul 18;(89). doi: 10.3791/50377.

41.

Clinical indications for implantation of the total artificial heart.

Thanavaro KL, Tang DG, Kasirajan V, Shah KB.

ASAIO J. 2014 Sep-Oct;60(5):594-6. doi: 10.1097/MAT.0000000000000111.

PMID:
25068777
42.

miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells.

Jin M, Zhang T, Liu C, Badeaux MA, Liu B, Liu R, Jeter C, Chen X, Vlassov AV, Tang DG.

Cancer Res. 2014 Aug 1;74(15):4183-95. doi: 10.1158/0008-5472.CAN-14-0404. Epub 2014 Jun 5.

43.

Tumor-suppressive functions of 15-Lipoxygenase-2 and RB1CC1 in prostate cancer.

Suraneni MV, Moore JR, Zhang D, Badeaux M, Macaluso MD, DiGiovanni J, Kusewitt D, Tang DG.

Cell Cycle. 2014;13(11):1798-810. doi: 10.4161/cc.28757. Epub 2014 Apr 14.

44.

Cancer stem cells: constantly evolving and functionally heterogeneous therapeutic targets.

Yang T, Rycaj K, Liu ZM, Tang DG.

Cancer Res. 2014 Jun 1;74(11):2922-7. doi: 10.1158/0008-5472.CAN-14-0266. Epub 2014 Apr 8.

45.

Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W species.

Liu B, Badeaux MD, Choy G, Chandra D, Shen I, Jeter CR, Rycaj K, Lee CF, Person MD, Liu C, Chen Y, Shen J, Jung SY, Qin J, Tang DG.

PLoS One. 2014 Mar 5;9(3):e90615. doi: 10.1371/journal.pone.0090615. eCollection 2014.

46.

The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells.

Shi Y, Liu C, Liu X, Tang DG, Wang J.

PLoS One. 2014 Mar 4;9(3):e90022. doi: 10.1371/journal.pone.0090022. eCollection 2014.

47.

Cancer stem cells and radioresistance.

Rycaj K, Tang DG.

Int J Radiat Biol. 2014 Aug;90(8):615-21. doi: 10.3109/09553002.2014.892227. Epub 2014 Mar 7. Review.

48.

Fracture of the total artificial heart pneumatic driveline after transition to the portable driver.

Shah KB, Volman RA, Harton S, Tang DG, Kasirajan V.

J Heart Lung Transplant. 2013 Oct;32(10):1041-3. doi: 10.1016/j.healun.2013.06.014. Epub 2013 Aug 2. No abstract available.

PMID:
23911297
49.

In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals.

Badeaux MA, Jeter CR, Gong S, Liu B, Suraneni MV, Rundhaug J, Fischer SM, Yang T, Kusewitt D, Tang DG.

Cell Cycle. 2013 Aug 1;12(15):2395-408. doi: 10.4161/cc.25402. Epub 2013 Jun 26.

50.

Octreotide for left ventricular assist device-related gastrointestinal hemorrhage: can we stop the bleeding?

Rennyson SL, Shah KB, Tang DG, Kasirajan V, Pedram S, Cahoon W, Malhotra R.

ASAIO J. 2013 Jul-Aug;59(4):450-1. doi: 10.1097/MAT.0b013e318295232d.

PMID:
23820288

Supplemental Content

Support Center